Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults (Q84539641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Daniela Vinhas Bertolini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Luciana Scarlazzari Costa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Inneke Marie van der Heijden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Helena Keiko Sato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Heloísa Helena de Sousa Marques

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

6 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

5482-5486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

Sporadic meningococcal disease in adults: results of a 5-year population-based study

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Meningococcal conjugate vaccines: efficacy and new combinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Immune response to conjugated meningococcal C vaccine in pediatric oncology patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Human immunity to the meningococcus. I. The role of humoral antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Meningococcal polysaccharide-protein conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Effect of group-A meningococcal vaccine in army recruits in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Neisseria meningitidis serogroup B: laboratory correlates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: the Italian epidemiological scenario

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

Meningococcal conjugate vaccines policy update: booster dose recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.069

10.1016/J.VACCINE.2012.06.069

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22771509%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference